Product Information
HALOPERIDOL DEC 50 MG/ML AMPUL is a generic product labeled by Patriot Pharmaceuticals, priced at $18.4332 per ML under NDC 10147092103. Its NADAC has been published 541 times since Nov 28, 2013.
FDA first approved this application on Jan 14, 1986.
The High Outlier badge above means this manufacturer's average price in the Haloperidol Decanoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/mL
Manufacturer
Patriot PharmaceuticalsNDC
10147092103
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
8/20/2025
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA018701FDA Approved
1/14/1986
On Market Since
6/17/2011
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 50 MG/ML AMPUL has been published 541 times since Nov 28, 2013, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.4332 per ML |
|---|---|
| All-time high | $25.9040 (May 11, 2016) |
| All-time low | $17.0685 (May 22, 2024) |
| Median price | $21.2067 |
| Average price | $21.3849 |
| Largest weekly change | +16.8% (Apr 20, 2016) |
| Weeks tracked | 541 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-8.2%
5Y
-10.6%
All
-16.0%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Patriot Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol Decanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 50 MG/ML AMPUL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 50 MG/ML AMPUL, manufactured by Patriot Pharmaceuticals, is $18.4332 per ML (NDC 10147092103), effective Aug 20, 2025.
How has the price of HALOPERIDOL DEC 50 MG/ML AMPUL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 50 MG/ML AMPUL has declined 16.0%. It has been tracked across 541 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 50 MG/ML AMPUL?
Since Nov 28, 2013, the NADAC for HALOPERIDOL DEC 50 MG/ML AMPUL has ranged from a low of $17.0685 (May 22, 2024) to a high of $25.9040 (May 11, 2016), with a median of $21.2067 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 50 MG/ML AMPUL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL DEC 50 MG/ML VIAL, is $6.5723 per ML — about 64% below HALOPERIDOL DEC 50 MG/ML AMPUL.
Who manufactures HALOPERIDOL DEC 50 MG/ML AMPUL?
HALOPERIDOL DEC 50 MG/ML AMPUL (NDC 10147092103) is labeled by Patriot Pharmaceuticals, and CMS classifies it as a generic product.